Hemophilia B, or the Christmas disease, is a common human disease caused by coagulation factor Ⅸ (FⅨ) deficiency. It is an X-linked recessive hereditary disease. Here we obtained FⅨ-knockout mouse strains with phenotype of hemophilia B with the CRISPR/Cas system efficiently. We chose the 8th exon as the target locus, and co-injected codon-optimized Cas9 mRNA with sgRNA of FⅨ into C57BL/6 mice zygotes. We obtained 60 mice in total and genotyped them by high resolution melting (HRM) and sequencing. The results showed the mutation rate was 85.0% in total, and 79.5% and 95.2% in males and females, respectively. No off-targets were detected in the similar locus by HRM. We future measured the FⅨ activity of each mice. The FⅨ: C of mutant mice were significantly below the normal level and reduced to 6.82% of wild-type mice. The activity assay demonstrated that all the mutant mice were lack of FⅨ. In summary, we have generated hemophilia B model mice with extreme efficiency, using the RNA-guided Cas9 nuclease gene editing system.
Qihan Wang,Cong Huai,Ruilin Sun,Hua Zhuang,Hongyan Chen,Jian Fei,Daru Lu
. A quick and efficient method to generate hemophilia B mouse models by the CRISPR/Cas system[J]. Hereditas(Beijing), 2015
, 37(11)
: 1143
-1148
.
DOI: 10.16288/j.yczz.15-117
[1] Giannelli F, Green PM, Sommer SS, Poon MC, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Figueiredo MS, Brownlee GG. Haemophilia B: Database of point mutations and short additions and deletions- eighth edition. Nucleic Acids Res , 1998, 26(1): 265-268.
[2] Kurachi K, Kurachi S, Furukawa M, Yao SN. Biology of factor Ⅸ. Blood Coagul Fibrinolysis , 1993, 4(6): 953-973.
[3] Wang LL, Zoppè M, Hackeng TM, Griffin JH, Lee KF, Verma IM. A factor Ⅸ-deficient mouse model for hemophilia B gene?therapy. Proc Natl Acad Sci USA , 1997, 94(21): 11563-11566.
[4] Lin HF, Maeda N, Smithies O, Straight DL, Stafford DW. A coagulation factor Ⅸ-deficient mouse model for human hemophilia B. Blood , 1997, 90(10): 3962-3966.
[5] Shen B, Zhang J, Wu HY, Wang JY, Ma K, Li Z, Zhang XG, Zhang PM, Huang XX. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res , 2013, 23(5): 720-723.
[6] Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science , 2012, 337(6096): 816-821.
[7] Cong L, Ran FA, Cox D, Lin SL, Barretto R, Habib N, Hsu PD, Wu XB, Jiang WY, Marraffini LA, Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science , 2013, 339(6121): 819-823.
[8] Wang HY, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell , 2013, 153(4): 910-918.
[9] Dahlem TJ, Hoshijima K, Jurynec MJ, Gunther D, Starker CG, Locke AS, Weis AM, Voytas DF, Grunwald DJ. Simple methods for generating and detecting locus-specific mutations induced with TALENs in the zebrafish genome. PLoS Genet , 2012, 8(8): e1002861.
[10] 曹春鸽, 孙海燕, 周芳芳, 王诗铭, 陈红岩, 卢大儒. 应用HRM技术对 CYP2C19 * 2 和 CYP2C19 * 3 进行双重SNP分型. 遗传, 2013, 35(7): 923-930.
[11] Fu YF, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol , 2013, 31(9): 822-826.
[12] Over J. Methodology of the one-stage assay of factor VIII (VIII: C). Scand J Haematol , 1984, 33(S41): 13-24.
